Eluminex

Suzhou, China · Founded 2020 · $90.0M raised

Headquarters
Suzhou
Founded
2020
Business Model
B2B
Total Funding
$90.0M
Last Round
$40.0M Series BFeb 2023
Rounds
2

About

Eluminex Biosciences is an ophthalmic biotechnology company committed to discovering and developing first-in-class and best-in-class therapies for vision-threatening eye diseases. Founded in February 2020 by Dr. Jinzhong Zhang and Dr. Zhenze John Hu, the company is headquartered in Suzhou Industrial Park with a business center in Shanghai. Eluminex raised a $50 million Series A in November 2020 co-led by Lilly Asia Ventures, GL Ventures (Hillhouse Capital), and Quan Capital, targeting both China and global markets with its innovative ophthalmic pipeline.

Summary

Eluminex is a Biotech company based in Suzhou, China, founded in 2020. It has raised $90.0M in total across 2 rounds, most recently a $40.0M Series B round in Feb 2023. Investors include Cenova Capital, Lilly Asia Ventures and GL Ventures.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BFeb 2023
$40.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Eluminex on Indexed.vc
<a href="https://indexed.vc/companies/eluminex"><img src="https://indexed.vc/api/badge/company/eluminex" alt="Eluminex on Indexed.vc" width="260" height="76" /></a>